Lv21
130 积分 2023-01-29 加入
Abstract 6754: Clinical characteristics, real-world treatment patterns, and clinical outcomes among patients with previously treated metastatic or unresectable EGFR-mutated non-small cell lung cancer in the United States
2小时前
求助中
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
2个月前
已完结
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
7个月前
已完结
Progress in the treatment of malignant ascites
10个月前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
10个月前
已完结
Abstract CT075: Updated overall survival outcomes from a randomized, double-blind phase III study of sintilimab versus placebo in combination with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma (ORIENT-15)
1年前
已关闭
Successful Osimertinib Rechallenge After Relapse Following Adjuvant Osimertinib: A Case Report
1年前
已完结
Abstract 6754: Clinical characteristics, real-world treatment patterns, and clinical outcomes among patients with previously treated metastatic or unresectable EGFR-mutated non-small cell lung cancer in the United States
1年前
已关闭
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer
1年前
已完结
PS1-2 First report of cohort 3 and mature survival data from the U31402-A-U102 study of HER3-DXd in EGFR-mutated NSCLC
1年前
已完结
Assessing the impact of nonspecific binding on oligonucleotide bioanalysis
2年前
已采纳
Single-cell RNA-Seq of human esophageal epithelium in homeostasis and allergic inflammation
2年前
已采纳
Unfolding the popularity of video conferencing apps – A privacy calculus perspective
2年前
已采纳
Concurrent chemoradiotherapy improves prognosis and quality of life of patients with metastatic and recurrent hepatocellular carcinoma
2年前
已采纳
皖公网安备34019202002308
